320 related articles for article (PubMed ID: 28523942)
41. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
43. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R
IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499
[TBL] [Abstract][Full Text] [Related]
44. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
45. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
46. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
47. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
[TBL] [Abstract][Full Text] [Related]
48. Multifunctional Nanographene Oxide for Targeted Gene-Mediated Thermochemotherapy of Drug-resistant Tumour.
Zeng Y; Yang Z; Li H; Hao Y; Liu C; Zhu L; Liu J; Lu B; Li R
Sci Rep; 2017 Mar; 7():43506. PubMed ID: 28272412
[TBL] [Abstract][Full Text] [Related]
49. Nucleic Acid Delivery System by the Combination of Lipid bubbles and Ultrasound.
Endo-Takahashi Y; Maruyama K; Negishi Y
Curr Pharm Des; 2018; 24(23):2673-2677. PubMed ID: 30084324
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in siRNA delivery.
Sarisozen C; Salzano G; Torchilin VP
Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
[TBL] [Abstract][Full Text] [Related]
51. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
Aigner A; Fischer D
Pharmazie; 2016 Jan; 71(1):27-34. PubMed ID: 26867350
[TBL] [Abstract][Full Text] [Related]
52. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
53. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
Sun H; Yarovoy I; Capeling M; Cheng C
Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
[TBL] [Abstract][Full Text] [Related]
54. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
[TBL] [Abstract][Full Text] [Related]
55. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
[TBL] [Abstract][Full Text] [Related]
56. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
[TBL] [Abstract][Full Text] [Related]
57. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
Peng Y; Huang J; Xiao H; Wu T; Shuai X
Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
[TBL] [Abstract][Full Text] [Related]
58. Lipid-based drug delivery systems for cancer treatment.
Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
[TBL] [Abstract][Full Text] [Related]
59. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
60. A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy.
Jang M; Han HD; Ahn HJ
Sci Rep; 2016 Aug; 6():32363. PubMed ID: 27562435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
